Safety and effectiveness of natalizumab re-dosing and treatment in the STRATA study

被引：0
|
作者：
Polman, Chris H. [1 ]
Goodman, Andrew [2 ]
Kappos, Ludwig [3 ]
Lublin, Fred [4 ]
O'Connor, Paul [5 ]
Rudick, Richard [6 ]
Jurgensen, Stephanie [7 ]
Lucas, Nisha [7 ]
Abdul-Ahad, Ayad [7 ]
Panzara, Michael [7 ]
机构：
[1] VU Med Ctr, Amsterdam, Netherlands
[2] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA
[3] Univ Basel Hosp, CH-4031 Basel, Switzerland
[4] Mt Sinai Sch Med, New York, NY USA
[5] St Michaels Hosp, Div Neurol, Toronto, ON M5B 1W8, Canada
[6] Cleveland Clin Fdn, Mellen Ctr Multiple Sclerosis Treatment & Res, Cleveland, OH 44195 USA
[7] Biogen Idec Inc, Cambridge, England
来源：
MULTIPLE SCLEROSIS | 2008年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S173 / S174
页数：2
相关论文
共 50 条
  • [21] Effectiveness of Natalizumab in Extended Dosing Interval
    Hervas, Jose Vicente
    Punet-Ortiz, Joan
    Teniente-Serra, Aina
    Mansilla, M. Jos
    Quirant-Sanchez, Bibiana
    Navarro, Juan
    Presas, Silvia
    Martinez-Caceres, Eva
    Ramo, Cristina
    NEUROLOGY, 2016, 86
  • [22] Effectiveness of natalizumab in extended dosing interval
    Ramo-Tello, C.
    Grau-Lopez, L.
    Vilaro, L.
    Segui, C.
    Delicado, S.
    Bonafont, X.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 213 - 214
  • [23] Safety and Feasibility of Parenchymal Re-Dosing of AAV2-hAADC into Non-Human Primate
    Taunque, Anitvir S.
    Rocco, Matthew T.
    Clark, Allison
    Dandamudi, Akhila
    Ceyhan, Kaya
    Travis, Meika
    Munjal, Vikas
    Bankiewicz, Krystof
    Samaranch, Lluis
    MOLECULAR THERAPY, 2024, 32 (04) : 835 - 836
  • [24] Novel acute therapies in the treatment of migraine: Impact of re-dosing on cost-utility outcomes
    Johnston, K. M.
    L'Italien, G. J.
    Harris, L.
    Deighton, A.
    Popoff, E.
    Powell, L.
    Coric, V
    HEADACHE, 2021, 61 : 162 - 162
  • [25] The effect of re-dosing of vasodilators on the intracavernosal pressure and on the penile rigidity
    de Meyer, JM
    Thibo, P
    EUROPEAN UROLOGY, 1998, 33 (03) : 293 - 296
  • [26] Novel acute therapies in the treatment of migraine: impact of re-dosing on cost-utility outcomes
    Johnston, Karissa M.
    L'italien, Gilbert
    Harris, Linda
    Deighton, Alison
    Popoff, Evan
    Croop, Robert
    Coric, Vladimir
    JOURNAL OF MEDICAL ECONOMICS, 2021, 24 (01) : 512 - 513
  • [27] Outcomes after late cladribine re-dosing in the Australian MSBase cohort
    Butzkueven, H.
    Spelman, T.
    Hodgkinson, S.
    Van der Walt, A.
    Buzzard, K.
    Skabina, O.
    Kalincik, T.
    Lechner-Scott, J.
    Macdonell, R.
    di Cantogno, E. Verdun
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 710 - 711
  • [28] A case of apparent re-dosing of atracurium during neostigmine reversal in a dog
    De Carellan, Alejandra Garcia
    Pelligand, Ludovic
    VETERINARY ANAESTHESIA AND ANALGESIA, 2013, 40 (03) : 334 - 336
  • [29] Efficacy and safety of natalizumab extended interval dosing
    Zeineddine, M.
    Ayyoubi, N.
    Tamim, H.
    Nicolas, J.
    Khoury, S.
    Yamout, B.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 871 - 871
  • [30] Five-year safety and efficacy data of natalizumab from the STRATA study
    Kappos, L.
    Goodman, A.
    Lublin, F.
    O'Connor, P.
    Polman, C.
    Cristiano, L. M.
    Forrestal, F.
    Duda, P.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 221 - 222
12345